The use of in-vitro kinetic models in the evaluation of beta-lactam/beta-lactamase inhibitor combinations.
Thorburn
C E
CE
SmithKline Beecham Pharmaceuticals, Betchworth, Surrey.
Slocombe
B
B
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004333:Drug Administration Routes; D004357:Drug Synergism; D005069:Evaluation Studies as Topic; D006801:Humans; D007700:Kinetics; D008826:Microbial Sensitivity Tests; D008954:Models, Biological; D001618:beta-Lactamases / Q000494:pharmacology*; D047090:beta-Lactams
D000900:Anti-Bacterial Agents; D047090:beta-Lactams; D001618:beta-Lactamases